4694 Stock Overview
Provides laboratory testing and related services in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
BML, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥3,000.00 |
| 52 Week High | JP¥3,115.00 |
| 52 Week Low | JP¥2,592.00 |
| Beta | 0.26 |
| 1 Month Change | 2.39% |
| 3 Month Change | 7.14% |
| 1 Year Change | 7.14% |
| 3 Year Change | -10.31% |
| 5 Year Change | -1.15% |
| Change since IPO | 110.81% |
Recent News & Updates
Shareholder Returns
| 4694 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 1.6% | 2.5% | 2.3% |
| 1Y | 7.1% | -7.3% | 1.8% |
Return vs Industry: 4694 exceeded the JP Healthcare industry which returned -7.3% over the past year.
Return vs Market: 4694 exceeded the JP Market which returned 1.8% over the past year.
Price Volatility
| 4694 volatility | |
|---|---|
| 4694 Average Weekly Movement | 4.5% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in JP Market | 9.3% |
| 10% least volatile stocks in JP Market | 3.0% |
Stable Share Price: 4694 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4694's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1955 | 4,513 | Kensuke Kondo | www.bml.co.jp |
BML, Inc. provides laboratory testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; special laboratory test, including RIA, cellular, immunological, and DNA analysis; and microbiological tests for medical and pharmaceutical societies and organizations; laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies, as well as develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures. It also provides medical information system services, which include electronic medical charts for networking medical information, as well as preventive medicine services.
BML, Inc. Fundamentals Summary
| 4694 fundamental statistics | |
|---|---|
| Market cap | JP¥117.02b |
| Earnings (TTM) | JP¥6.26b |
| Revenue (TTM) | JP¥143.19b |
Is 4694 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4694 income statement (TTM) | |
|---|---|
| Revenue | JP¥143.19b |
| Cost of Revenue | JP¥97.33b |
| Gross Profit | JP¥45.86b |
| Other Expenses | JP¥39.60b |
| Earnings | JP¥6.26b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 160.56 |
| Gross Margin | 32.03% |
| Net Profit Margin | 4.37% |
| Debt/Equity Ratio | 0% |
How did 4694 perform over the long term?
See historical performance and comparisonDividends
Does 4694 pay a reliable dividends?
See 4694 dividend history and benchmarks| BML dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 30 2025 |
| Days until Ex dividend | 66 days |
| Days until Dividend pay date | 28 days |
Does 4694 pay a reliable dividends?
See 4694 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/01 15:14 |
| End of Day Share Price | 2025/05/30 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BML, Inc. is covered by 8 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mitsuko Miyasako | Barclays |
| Hidemaru Yamaguchi | Citigroup Global Markets Japan Inc. |
| Yuki Yamazaki | Daiwa Securities Co. Ltd. |